Neal Shore, MD, FACS, discussed findings from the SunRISe-4 trial of TAR-200 and cetrelimab in muscle-invasive bladder cancer ...
If NVIDIA’s GTC 2025 is any indication, this shift is moving at a pace faster than anyone anticipated. Notably, NVIDIA’s leap ...
Between brutalism and postmodernism, and masters such as Aldo Rossi, the BBPR and the Smithsons, a journey through those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback